The Chicago Infectious Disease Board Review 2018

The Chicago Infectious Disease Board Review 2018

Rush University Medical Center Board Review

Get a Comprehensive Look at Infectious Disease

This extensive, well-laid-out CME board review includes case-based lectures on topics like central nervous system infections, nosocomial infections and infection control, antibiotics and mechanisms of resistance, and viral hepatitis, with special focus on the latest developments, medical guidelines, and therapeutic strategies. The Chicago Infectious Disease Board Review will help you to better:

• Apply appropriate diagnostic procedures for common and uncommon infectious diseases
• Recognize the presenting signs and symptoms of STDs and effectively treat them
• Integrate current guidelines for the treatment of febrile transplant recipients
• Prescribe appropriate antimicrobial therapy for patients with suspected sepsis
• Reduce nosocomial infections by implementing effective infection control measures
• Maintain up-to-date immunization of patients as per currently recommended adult immunization schedules

Expand Your Skills

Available online or via audio CDs, The Chicago Infectious Disease Board Review provides a maximum of 26.25 AMA PRA Category 1 Credits ™ and access to unbiased, evidence-based content and case-based reviews so you can expand your knowledge and incorporate the latest guidelines into your daily practice.

Accreditation

In support of Improving Patient Care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team.

Designation

Rush University Medical Center designates this enduring material for a maximum of 26.25 AMA PRA Category 1 credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Date of Original Release: November 16, 2018

Date Credits Expire: November 15, 2021

Disclosure

It is the policy of the Rush University Medical Center Office of Continuing Medical Education to ensure that its CME activities are independent, free of commercial bias and beyond the control of persons or organizations with an economic interest in influencing the content of CME. Everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest (including but not limited to pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic) within the preceding 12 months. If there are relationships that create a conflict of interest, these must be resolved by the CME Course Director in consultation with the Office of Continuing Medical Education prior to the participation of the faculty member in the development or presentation of course content.

Disclosure information for all individuals in control of the content of the activity is located on the disclosure statement in the PDF and printed syllabus.

Learning Objectives

At the conclusion of this activity, the participant will be able to:

• Utilize appropriate microbiologic diagnostic procedures for the diagnosis of common and uncommon infectious diseases
• Maintain up-to-date immunization of my patients for all currently recommended adult immunizations
• Provide my patients traveling to foreign destinations with the United States Public Health Service recommended prophylactic medications and immunizations
• Initiate antiretroviral therapy in HIV infected patients based upon current recommendations of the Department of Health and Human Services
• Initiate treatment for suspected sexually transmitted diseases based upon the presenting symptoms and signs
• Initiate therapy for chronic HBV and HCV infection based upon current recommendations
• Isolate hospitalized patients suspected of having infections with microbiologic agent of bioterrorism or a multidrug resistant organism
• Treat community and healthcare acquired pneumonia with the current IDSA Guidelines recommended antimicrobial agents
• Prescribe appropriate antimicrobial therapy for patients with suspected sepsis
• Utilize current recommended guidelines for the treatment of febrile transplant recipients
• Initiate appropriate infection control procedures to limit the acquisition of hospital acquired infections

Intended Audience

This educational activity was designed for fellows, practicing Infectious Disease specialists, and other healthcare workers with an interest in Infectious Disease.

Topics/Speaker:

Syndromes

• Central Nervous System Infections – Michael Lin, MD, MPH

• Upper and Lower Respiratory and Head and Neck Infections – David Schwartz, MD

• Infective Endocarditis – John Segreti, MD

• Diarrhea and Gastrointestinal Syndromes – Temitope Oyedele, MD

• Skin and Soft Tissue Infections and Toxin Associated Diseases – Kathy Rezai, MD

• Bone and Joint Infections – John Segreti, MD

• Healthcare Epidemiology and Infection Control – Michael Lin, MD, MPH

• Fever of Unknown Origin – Shivanjali Shankaran, MD

Specific Infectious Diseases

• Epidemiology and Treatment of Staphylococcus Aureus Infections – Kyle Popovich, MD, MS

• Sexually Transmitted Diseases – Kyle Popovich, MD, MS

• Lyme Disease – Sarah Won, MD, MPH

• Other Borrelia, Rickettsia, Tick-borne and Other Ectoparasitic Diseases – Sarah Won, MD, MPH

• Tuberculosis and Non-Tuberculous Mycobacteria – Shivanjali Shankaran, MD

• Uncommon Pulmonary Infections and Higher Order Bacteria – Brett Williams, MD

• Invasive Fungal Infections – Laurie Proia, MD

• Viral Hepatitis – Oluwatoyin M. Adeyemi, MD

• Bacterial Zoonoses and Viral Hemorrhagic Fevers – Brett Williams, MD

• Herpesviruses, HTLV-1, Prion Diseases – Gregory Huhn, MD, MPHTM

• Parasites – Kamal Singh, MD, D (ABMM)

• Helminths – Kamal Singh, MD, D (ABMM)

HIV

• HIV and Opportunistic Infections – Mariam Aziz, MD

• HIV and HAART – Mariam Aziz, MD

Non-HIV Immunocompromised Hosts

• Infections in Solid Organ Transplant (SOT) Recipients – Carlos Santos, MD, MPHS

• Infections in Stem Cell Transplant (HSCT) Recipients – Carlos Santos, MD, MPHS

Antimicrobials and Vaccines

• Antibiotics and Mechanisms of Resistance – Part I – Amy Hanson, PharmD, BCPS AQ-ID

• Antibiotics and Mechanisms of Resistance – Part II – Christy Varughese, PharmD

• Immunizations – Beverly Sha, MD

Microbiology and Immunology

• Clinical Microbiology – Nicholas Moore, PhD, MLS (ASCP)CM

• Primary Immune Deficiencies – Allan Tenorio, MD

Product Details